Technical Validation of a Novel Label-Independent Device to Capture Circulating Tumor Cells

Circulating tumor cells (CTCs) are tumor derived biomarkers found in the blood of cancer patients with a wide range of clinical utility. This scientific poster explores the use of ANGLE’s Parsortix System as a novel marker-independent separation device for tumor cell enrichment, aiming to validate it as an effective device for the enrichment of epithelial and/or mesenchymal-like CTCs.